NEPHRO PROTECTIVE ACTIVITY OF MERREMIA EMARGINATA BURM AGAINST CIS-PLATIN INDUCED NEPHROTOXIC RATS.

Authors

  • Sudhavani.V*,Chinnikrishnaiah.V,RaghuMoorthy.V,Raghavendra.H.G,RangaNayakulu.D

Keywords:

Merremia emarginata, cisplatin, nephrotoxicity, nephroprotection, oxidative stress, antioxidants, renal injury.

Abstract

Cisplatin is an effective anticancer drug, but its clinical use is limited by dose-dependent nephrotoxicity. Oxidative stress, inflammation, mitochondrial dysfunction, and tubular epithelial injury are among the major mechanisms involved in cisplatin-induced renal damage. Merremia emarginata Burm. is a medicinal plant traditionally used for various therapeutic purposes and contains bioactive phytochemicals with antioxidant and anti-inflammatory potential. The aim of this study is to evaluate the nephroprotective potential of M. emarginata against cisplatin-induced nephrotoxicity in rats. A literature-based experimental framework was considered with emphasis on serum creatinine, blood urea nitrogen, renal antioxidant status, lipid peroxidation, and histopathological changes. The available pharmacological evidence suggests that plant-derived antioxidants may reduce cisplatin-associated renal injury by limiting reactive oxygen species formation and preserving endogenous antioxidant defenses. Further experimental studies are required to establish the specific efficacy, optimal dose, and active constituents of M. emarginata in this model.

References

Pabla N, Dong Z. Cisplatin nephrotoxicity: Mechanisms and renoprotective strategies. Kidney International. 2008;73(9):994–1007.

Miller RP, Tadagavadi RK, Ramesh G, Reeves WB. Mechanisms of cisplatin nephrotoxicity. Toxins. 2010;2(11):2490–2518.

Khare CP. Indian Medicinal Plants: An Illustrated Dictionary. Springer; 2007.

Halliwell B, Gutteridge JMC. Free Radicals in Biology and Medicine. 5th ed. Oxford University Press; 2015.

Arany I, Safirstein RL. Cisplatin nephrotoxicity. Seminars in Nephrology. 2003;23(5):460–464.

Ozkok A, Edelstein CL. Pathophysiology of cisplatin-induced acute kidney injury. BioMed Research International. 2014;2014:967826.

Downloads

Published

2010-03-01